Modeling the interaction between quinolinate and the receptor for advanced glycation end products (RAGE): relevance

Iris N Serratos1, Pilar Castellanos2, Nina Pastor3

  • 1Departamento de Química, Universidad Autónoma Metropolitana-Iztapalapa, México D.F., México; Laboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, SSA, México D.F., México.

Plos One
|March 11, 2015
PubMed

Insights

The receptor for advanced glycation end products (RAGE) binds quinolinate (QUIN), triggering toxic cell signaling. This interaction, involving RAGE

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Toxicology

Background:

  • The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor implicated in neurodegenerative and inflammatory conditions.
  • RAGE activation by various ligands initiates cellular signaling pathways.
  • Increased RAGE expression is linked to quinolinate (QUIN)-induced neurotoxicity.

Purpose of the Study:

  • To investigate the early toxic events and signaling cascades induced by QUIN, potentially leading to cell death.
  • To characterize the extent of early cellular damage in the rat striatum mediated by RAGE.
  • To elucidate the direct molecular interaction between QUIN and RAGE.

Main Methods:

  • Image processing techniques were employed to quantify early cellular damage in the rat striatum.
  • Fluorescence assays were used to determine the binding constant (Kb) between the RAGE VC1 domain and QUIN.
  • Molecular modeling was utilized to predict binding sites of QUIN within the RAGE VC1 domain for both rat and human RAGE.

Main Results:

  • QUIN was observed to bind to multiple sites on the RAGE VC1 dimer.
  • These binding interactions suggest distinct mechanistic pathways for QUIN-induced signaling.
  • Some binding events were found to directly alter RAGE oligomerization, impacting receptor function.

Conclusions:

  • This study clarifies the molecular recognition between RAGE and QUIN.
  • The findings reveal how QUIN binding modulates RAGE function through altered oligomerization and signaling.
  • Understanding RAGE-QUIN interactions is crucial for developing therapeutic strategies against neurotoxicity.